GlassScriptPhysician profile
Catherine Jahn
NPI 1114367158
$1,485.21
in general payments reported to CMS, 2019-2025
18 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $172 · 2022: $220 · 2023: $308 · 2024: $408 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $579.54 | 2022-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $298.98 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $91.36 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $88.73 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $75.97 | 2022 | |
| Corcept Therapeutics | $59.29 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $51.46 | 2024-2025 | Lagevrio, Dificid |
| Pfizer INC. | $36.29 | 2025 | |
| Sanofi-Aventis U.S. LLC | $32.82 | 2022-2025 | |
| Glaxosmithkline, LLC. | $30.44 | 2021-2023 | Bexsero, Arexvy |
| Astellas Pharma US INC | $21.98 | 2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $21.90 | 2025 | Rexulti |
| Ardelyx, INC. | $18.52 | 2024 | Ibsrela |
| Bigfoot Biomedical INC | $16.96 | 2021 | |
| Daiichi Sankyo INC. | $16.55 | 2024 | Injectafer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.99 | 2021 | |
| Ibsa Pharma INC. | $14.87 | 2024 | Licart, Tirosint |
| Janssen Pharmaceuticals, INC | $14.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Jahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.